biomarin
BioMarin is seeking a Senior Scientist 2 to provide nonclinical pharmacology and toxicology expertise for the development of small molecule and biologic drug candidates. This role involves designing, implementing, and interpreting nonclinical studies while contributing to the strategic development of therapeutics from late-stage research through commercialization. The successful candidate will collaborate with cross-functional teams and regulatory agencies to support drug development and ensure compliance with Good Laboratory Practices.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
biomarin didn’t post a salary, so this is our estimate from similar listings.
Regulatory/Project Toxicologist
Roche
Sr. Scientist, Toxicology
Legend Biotech
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Distinguished Scientist, Safety Assessment Project Expert
sanofi us
Vice President of Nonclinical Drug Safety and Toxicology
Remix Therapeutics
Senior Toxicologist
Regeneron Pharmaceuticals